Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Neurochemistry International|February 16, 2013
Neuropeptide S inhibits release of 5-HT and glycine in mouse amygdala and frontal/prefrontal cortex through activation of the neuropeptide S receptorElena Gardella, Cristina Romei, Anna Cavallero, et al.
Annales D'Endocrinologie|May 5, 2019
Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinomaRossella Elisei, Valeria Bottici, Virginia Cappagli, et al.
Endocrine|July 7, 2019
Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomasTeresa Ramone, Cristina Romei, Raffaele Ciampi, et al.
Head & Neck|March 23, 2018
Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinomaVincenzo Condello, Elisabetta Macerola, Clara Ugolini, et al.
Molecular and Cellular Endocrinology|June 24, 2008
Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumorsRaffaele Ciampi, Agnese Vivaldi, Cristina Romei, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2004
RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general populationRossella Elisei, Barbara Cosci, Cristina Romei, et al.
Cancers|July 2, 2021
Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New DrugsAlessandro Prete, Antonio Matrone, Carla Gambale, et al.
The Journal of Clinical Endocrinology and Metabolism|March 25, 2025
Prevalence and Genetics of "De Novo" Men2 SyndromesRoberta Casalini, Cristina Romei, Valeria Bottici, et al.
Thyroid : Official Journal of the American Thyroid Association|November 25, 2020
Ca19.9 Positivity and Doubling Time Are Prognostic Factors of Mortality in Patients with Advanced Medullary Thyroid Cancer with No Evidence of Structural Disease Progression According to Response Evaluation Criteria in Solid TumorsLoredana Lorusso, Cristina Romei, Paolo Piaggi, et al.
Oncotarget|March 9, 2018
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastasesCristina Romei, Raffaele Ciampi, Francesca Casella, et al.
Pageof 11